TRex Bio Funding & Investors
South San Francisco, CA
TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases.
trex.bioTotal Amount Raised: $169,000,000
TRex Bio Funding Rounds
Series B
$84,000,000
Series B Investors
Delos CapitalAvego Bioscience CapitalAgent CapitalPolaris PartnersSV HEALTH INVESTORSEli Lilly & Company FoundationPfizerAlexandria Venture InvestmentsJohnson & Johnson Innovation – JJDCSeries A
$26,000,000
Series A Investors
Polaris PartnersSV HEALTH INVESTORSEli Lilly & Company FoundationAlexandria Venture InvestmentsPfizerLaurion Capital ManagementJohnson & Johnson Innovation – JJDCSeries A
$59,000,000
Series A Investors
Alexandria Venture InvestmentsJohnson & Johnson Robotics and Digital SolutionsSV HEALTH INVESTORSPfizerEli Lilly and Company
Funding info provided by Diffbot.